Rosmarinic acid cannot penetrate the bloodbrain barrier via oral administration, and even after intraperitoneal or intravenous injection, only extremely low levels are detected in the brain, failing to reach effective pharmacological concentrations (Puris et al., 2019)
Changes in dosage/medication and refills may require additional appointments
Additionally, 100 M MDL29,951 (Figure 3C), but not 100 nM MDL29,951 (Figure S2A), further inhibited GLP-1 secretion when GLUTag cells were stimulated with 1 M forskolin and 10 M IBMX
In large part, that rebound was fueled by increasing demand for weight-loss drugs such as GLP-1 agonists and semaglutide treatments, including Ozempic, Wegovy, Zepbound, and Mounjaro